-
Something wrong with this record ?
Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats
L. Figueroa-Valverde, F. Diaz-Cedillo, M. Lopez-Ramos, E. Garcia-Cervera, E. Pool-Gomez, C. Cardena-Arredondo, G. Ancona-Leon
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
- MeSH
- Alloxan MeSH
- Diabetes Mellitus, Experimental blood MeSH
- Drug Combinations MeSH
- Glyburide analogs & derivatives pharmacokinetics therapeutic use MeSH
- Hypoglycemic Agents pharmacokinetics metabolism MeSH
- Blood Glucose metabolism MeSH
- Rats MeSH
- Metformin therapeutic use MeSH
- Rats, Wistar MeSH
- Pregnenolone pharmacokinetics therapeutic use MeSH
- Tissue Distribution MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additionalAIM was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12039736
- 003
- CZ-PrNML
- 005
- 20140324112722.0
- 007
- ta
- 008
- 121217s2012 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2012.028 $2 doi
- 035 __
- $a (PubMed)22660215
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Figueroa-Valverde, Lauro $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico. lauro_1999@yahoo.com
- 245 10
- $a Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats / $c L. Figueroa-Valverde, F. Diaz-Cedillo, M. Lopez-Ramos, E. Garcia-Cervera, E. Pool-Gomez, C. Cardena-Arredondo, G. Ancona-Leon
- 520 9
- $a AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additionalAIM was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
- 650 _2
- $a alloxan $7 D000496
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní glukóza $x metabolismus $7 D001786
- 650 _2
- $a experimentální diabetes mellitus $x krev $7 D003921
- 650 _2
- $a fixní kombinace léků $7 D004338
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glibenklamid $x analogy a deriváty $x farmakokinetika $x terapeutické užití $7 D005905
- 650 _2
- $a hypoglykemika $x farmakokinetika $x metabolismus $7 D007004
- 650 _2
- $a metformin $x terapeutické užití $7 D008687
- 650 _2
- $a pregnenolon $x farmakokinetika $x terapeutické užití $7 D011284
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a tkáňová distribuce $7 D014018
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Diaz-Cedillo, Francisco $u Escuela Nacional de Ciencias Biologicas del Instituto Politecnico Nacional. Prol. Carpio y Plan de Ayala s/n Col. Santo Tomas, D.F. C.P. 11340, Mexico
- 700 1_
- $a Lopez-Ramos, Maria $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
- 700 1_
- $a Garcia-Cervera, Elodia $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
- 700 1_
- $a Pool-Gomez, Eduardo $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
- 700 1_
- $a Cardena-Arredondo, Carlos $u Centro Estatal de Oncologia, Campeche Cam., Mexico
- 700 1_
- $a Ancona-Leon, Graciela $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico $7 gn_A_00005912
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 156, č. 2 (2012), s. 122-127
- 856 41
- $u http://biomed.papers.upol.cz/magno/bio/2012/mn2.php $y domovská stránka časopisu - plný text volně přístupný = fulltext
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20121217 $b ABA008
- 991 __
- $a 20140324112755 $b ABA008
- 999 __
- $a ok $b bmc $g 963288 $s 797324
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 156 $c 2 $d 122-127 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK138 $a Pubmed-20121217